India's top bourses -National Stock Exchange, BSE and Metropolitan Stock Exchange of India, on Wednesday, provided an update to the decision taken on February 9 regarding licensing of Indian Indices and sharing of Market Data of the listed securities. 

SEBI has given approval to BSE for launching Cross Currency Derivative and Cross INR Options.

Indoco Remedies zoomed close to 7 per cent on the bourses in Friday morning trade after the company announced receiving a certification for its Goa plant.

The world’s third largest economy, Japan, has managed to grow for the eight successive quarter which is also its largest successful run since the financial bubble of the late 1980s.

The share price of Punjab National Bank (PNB) plummeted about 8 per cent in morning trade on Wednesday after the bank detected some fraudulent transactions of about Rs. 11,000 Crore in one of its Mumbai branch.

The stocks that are likely to witness significant movement on the bourses on February 14 are NTPC Limited, Precision Camshafts, Sandu Pharmaceuticals, Emami Infrastructure, Jaypee Infratech, Kiri Industries, Chambal Fertilizers and Canara Bank.

NTPC on Tuesday announced that it has won a tender for supplying 300 megawatts electricity to Bangladesh for 15 years.

The National Pharmaceuticals Pricing Authority (NPPA), India’s drug pricing regulator, on Monday, revised the prices of coronary stents.

IndoStar Capital Finance, a non-banking finance company, has filed draft papers with Securities and Exchange Board of India to raise about Rs. 2,000 crore through an initial public offer (IPO).

Galaxy Surfactants, a speciality chemicals manufacturer, debuted on the bourses on Thursday at a 3 per cent premium.